Latest News

/Latest News

PROTOM INTERNATIONAL ACCELERATES FOCUS ON MGH PROTON THERAPY INSTALLATION

Radiance 330® Proton Therapy System to be installed at Massachusetts General Hospital Flower Mound, Texas USA -- ProTom International ("ProTom") is pleased to announce its accelerated focus on the installation of its Radiance 330® Proton Therapy System ("Radiance 330") to be housed in the Massachusetts General Hospital ("MGH") Department of Radiation Oncology. For the first [...]

By | July 6th, 2016|Latest News|0 Comments

PROTOM INTERNATIONAL ANNOUNCES PURCHASE AGREEMENT

Radiance 330® Proton Therapy System to be installed at Massachusetts General Hospital Flower Mound, Texas USA -- ProTom International ("ProTom") is pleased to announce the execution of a purchase agreement with Massachusetts General Hospital ("MGH") for the acquisition of a Radiance 330® Proton Therapy System ("Radiance 330") to be housed in the MGH Department of [...]

By | July 6th, 2016|Latest News|0 Comments

PROTOM INTERNATIONAL RECEIVES FDA 510(k) CLEARANCE FOR ITS RADIANCE 330® PROTON THERAPY SYSTEM

ProTom International, the developer and manufacturer of a technologically advanced proton beam radiation therapy system, announced today it has received 510(k) clearance for its Radiance 330 Proton Therapy System. The Radiance 330 is a compact, modular and more affordable proton beam delivery system for the treatment of patients with cancer. The system delivers extremely focused, [...]

By | July 6th, 2016|Latest News|0 Comments

PROTOM INTERNATIONAL’S PROTON CANCER THERAPY TECHNOLOGY A TEXAS BIOTECH SUCCESS STORY

https://bionews-tx.com/news/2014/05/14/protom-international-inc-s-proton-cancer-therapy-technology-a-texas-biotech-success-story/

By | July 6th, 2016|Latest News|0 Comments

COMPACT PROTON THERAPY TECHNOLOGY ACHIEVES SCHEDULED DECEMBER 2012 MILESTONE OF BEAM AT GANTRY ROOM ISOCENTER

PRESS RELEASE December 12, 2012 Flower Mound, Texas/Flint, Michigan, USA — Testing of a compact cancer-treatment technology from ProTom International (“ProTom”) demonstrated last week that the system achieves its design specification: delivering high-energy protons to isocenter at a beam intensity sufficient for standard clinical practice. The ProTom technical team measured stable and reproducible performance on [...]

By | July 6th, 2016|Latest News|0 Comments

PROTOM: A TEXAS BIOTECH SUCCESS STORY

Flower Mound, Texas-based BioTech startup ProTom International has received FDA 510(k) Clearance for its Radiance 330 ® Proton Therapy System. This clearance, officially making Radiance 330 ® commercially available, was instrumental in ProTom being awarded two new system orders — one at Massachusetts General Hospital (MGH), Boston and another at Atlantic Health System, New Jersey.

By | June 27th, 2016|Latest News|0 Comments